<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31448243</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><PubDate><Year>2019</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.</ArticleTitle><Pagination><StartPage>277</StartPage><MedlinePgn>277</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">277</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2019.00277</ELocationID><Abstract><AbstractText>Hand, foot, and mouth disease (HFMD) is a global health concern, especially in the Asia-Pacific region. HFMD caused by Enterovirus 71 (EV71) and Coxsackievirus A16 (CVA16) infection is usually self-limited but occasionally leads to severe pulmonary edema, neurological complications, and even death. Unfortunately, no effective drugs are currently available in clinical practice for the prevention and treatment of HFMD. Thus, anti-HFMD drugs must be urgently developed. A previous study had reported that lycorine could inhibit EV71 replication. In the present study, we found that LY-55, a lycorine derivative, inhibited the replication of EV71 and CVA16 <i>in vitro</i> and provided partial protection to mice from EV71 infection, as indicated by the decreased viral load and protein expression levels in muscles, clinical scores, and increased survival rates of infected mice. Mechanistically, LY-55 was not directly viricidal. Instead, the LY-55-mediated inhibition of EV71 and CVA16 was found to be mechanistically possible, at least in part, through downregulating autophagy, which plays an important role for EV71 and CVA16 replication. These findings suggest that LY-55 could be a potential lead or supplement for the development of anti-HFMD agents in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huiqiang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Jiamusi University, Jiamusi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yajun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Lian</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Jiamusi University, Jiamusi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Xiandao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuhuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>CAMS Key Laboratory of Antiviral Drug Research, Institute of Medicinal Biotechnology, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Antimicrobial Agents, Institute of Medicinal Biotechnology, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C105660">8-(2-furyl)-2-(di-n-propylamino)tetralin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013764">Tetrahydronaphthalenes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013764" MajorTopicYN="N">Tetrahydronaphthalenes</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LY-55</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">coxsackievirus A 16 (CVA16)</Keyword><Keyword MajorTopicYN="N">enterovirus 71 (EV71)</Keyword><Keyword MajorTopicYN="N">lycorine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31448243</ArticleId><ArticleId IdType="pmc">PMC6692562</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2019.00277</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bao J. F., Shi Y. F., Tao M., Liu N., Zhuang S. G., Yuan W. J. (2018). Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy. Clin. Sci. 132, 2299&#x2013;322. 10.1042/CS20180563</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180563</ArticleId><ArticleId IdType="pmc">PMC6376616</ArticleId><ArticleId IdType="pubmed">30293967</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle K. B., Randow F. (2013). The role of &#x2018;eat-me' signals and autophagy cargo receptors in innate immunity. Curr. Opin. Microbiol. 16, 339&#x2013;348. 10.1016/j.mib.2013.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2013.03.010</ArticleId><ArticleId IdType="pubmed">23623150</ArticleId></ArticleIdList></Reference><Reference><Citation>China Center For Disease Control Prevention  (2017). Overview of the Legal Epidemic Situation of Infectious Diseases in China in 2017. Available online at: http://www.nhc.gov.cn/jkj/s3578/201802/de926bdb046749abb7b0a8e23d929104.shtml</Citation></Reference><Reference><Citation>Fu Y. X., Xu W. T., Chen D. Y., Feng C. H., Zhang L., Wang X. H., et al. . (2015). Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication. Antiviral. Re. 124, 43&#x2013;53. 10.1016/j.antiviral.2015.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.09.016</ArticleId><ArticleId IdType="pubmed">26515789</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao G. Y., Ma J., Lu P., Jiang X., Chang C. (2018). Ophiopogonin B induces the autophagy and apoptosis of colon cancer cells by activating JNK/c-Jun signaling pathway. Biomed. Pharmacother. 108, 1208&#x2013;1215. 10.1016/j.biopha.2018.06.172</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.06.172</ArticleId><ArticleId IdType="pubmed">30372822</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Wang Y. X., Cao L., Wang P., Qing J., Zheng Q. Z., et al. . (2016). A conserved inhibitory mechanism of a lycorine derivative against enterovirus and hepatitis C virus. Antimicrob. Agents Chemother. 60, 913&#x2013;924. 10.1128/AAC.02274-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02274-15</ArticleId><ArticleId IdType="pmc">PMC4750679</ArticleId><ArticleId IdType="pubmed">26596952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu M., Peng S. H., He Y. D., Qin M., Cong X. N., Xing Y. J., et al. . (2015). Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer. Oncotarget 6, 15348&#x2013;15361. 10.18632/oncotarget.3610</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.3610</ArticleId><ArticleId IdType="pmc">PMC4558156</ArticleId><ArticleId IdType="pubmed">25915156</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S. C., Chang C. L., Wang P. S., Tsai Y., Liu H. S. (2009). Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J. Med. Virol. 81, 1241&#x2013;1252. 10.1002/jmv.21502</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21502</ArticleId><ArticleId IdType="pmc">PMC7166624</ArticleId><ArticleId IdType="pubmed">19475621</ArticleId></ArticleIdList></Reference><Reference><Citation>Journal of Medicinal Chemistry  (2019). Author Guidelines. Available online at: https://pubs.acs.org/page/jmcmar/submission/authors.html</Citation></Reference><Reference><Citation>Kang J. J., Zhang Y. S., Ca,o X., Fan J., Li G. L., Wang Q., et al. . (2012). Lycorine inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in RAW264.7 cells through suppressing P38 and STATs activation and increasesthe survival rate of mice after LPS challenge. Int. Immunopharmacol. 12, 249&#x2013;256.10.1016/j.intimp.2011.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2011.11.018</ArticleId><ArticleId IdType="pubmed">22155741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. R., Wang P. S., Wang J. R., Liu H. S. (2014). Enterovirus 71-induced autophagy increases viral replication and pathogenesis in a suckling mouse model. J. Biomed. Sci. 21:80. 10.1186/s12929-014-0080-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-014-0080-4</ArticleId><ArticleId IdType="pmc">PMC4237791</ArticleId><ArticleId IdType="pubmed">25139436</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Liu Y. Y., Hou X. L., Peng H. J., Zhang L., Jiang Q. B., et al. . (2013). Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro. PLoS ONE 8:e76007. 10.1371/journal.pone.0076007</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076007</ArticleId><ArticleId IdType="pmc">PMC3786884</ArticleId><ArticleId IdType="pubmed">24098754</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J. N., Yang Y. J., Xu Y. F., Ma C. M., Qin C., Zhang L. F. (2011). Lycorine reduced mortality of human enterovirus 71-infected mice by inhibiting virus replication. Virol. J. 8, 483&#x2013;491. 10.1186/1743-422X-8-483</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-483</ArticleId><ArticleId IdType="pmc">PMC3212826</ArticleId><ArticleId IdType="pubmed">22029605</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P. C. (2012). Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr. Opin. Virol. 2, 199&#x2013;205. 10.1016/j.coviro.2012.02.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu X., Wang H. R., Li Y., Fan W. B., Yu S. (2013). Antiviral activity of GuiQi polysaccharides against enterovirus 71 in vitro. Virol. Sin. 28, 352&#x2013;359. 10.1007/s12250-013-3376-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-013-3376-8</ArticleId><ArticleId IdType="pmc">PMC8208325</ArticleId><ArticleId IdType="pubmed">24254889</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y. Y., He X. H., Zhu G. G., Tu H. L., Liu Z. C., Li W. H., et al. . (2015). Coxsackievirus A16 Elicits Incomplete Autophagy Involving the mTOR and ERK Pathways. PLoS ONE 10:e0122109. 10.1371/journal.pone.0122109</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122109</ArticleId><ArticleId IdType="pmc">PMC4390341</ArticleId><ArticleId IdType="pubmed">25853521</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavin S. A., Leonard A., Grose V., Fazal F., Rahman A. (2018). Autophagy inhibitor 3-methyladenine protects against endothelial cell barrier dysfunction in acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 314, L388&#x2013;L396. 10.1152/ajplung.00555</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00555</ArticleId><ArticleId IdType="pmc">PMC5900361</ArticleId><ArticleId IdType="pubmed">29074492</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Hu Y. J., Li J. Q., Zheng H. W., Wang J. J., Guo L., et al. . (2018). Suppression of the toll-like receptor 7-dependent type I interferon production pathway by autophagy resulting from enterovirus 71 and coxsackievirus A16 infections facilitates their replication. Arch. Virol. 163, 135&#x2013;144. 10.1007/s00705-017-3592-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-017-3592-x</ArticleId><ArticleId IdType="pmc">PMC5756282</ArticleId><ArticleId IdType="pubmed">29052054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. Q., Li K., Ma L. L., Wu S., Hu J., Yan H. Y., et al. . (2017). Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy. Virol. J. 14:2. 10.1186/s12985-016-0674-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0674-4</ArticleId><ArticleId IdType="pmc">PMC5234143</ArticleId><ArticleId IdType="pubmed">28081706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. Q., Meng S., Li Z. R., Peng Z. G., Han Y. X., Guo S. S., et al. . (2013). The antiviral effect of 7-hydroxyisoflavone against Enterovirus 71 in vitro. J. Asian Nat. Prod. Res. 15, 382&#x2013;389. 10.1080/10286020.2013.770737</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10286020.2013.770737</ArticleId><ArticleId IdType="pubmed">23464760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. Q., Zhang D. J., Ge M., Li Z. R., Jiang J. D., Li Y. H. (2015). Formononetin inhibits enterovirus 71 replicationby regulating COX- 2/PGE2 expression. Virol. J. 12:35 10.1186/s12985-015-0264-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-015-0264-x</ArticleId><ArticleId IdType="pmc">PMC4351682</ArticleId><ArticleId IdType="pubmed">25890183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H. Q., Zhong M., Li Y. P., Li K., Wu S., Guo T. T., et al. . (2018). APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity. Antiviral. Res. 165, 23&#x2013;33. 10.1016/j.antiviral.2019.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.03.005</ArticleId><ArticleId IdType="pubmed">30862444</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Li L. F., Wang Q. Y., Shang L. Q., Shi P. Y., Yin Z. (2014). Anti-dengue-virus activity andstructure-activity relationship studies of lycorine derivatives. Chem. Med. Chem. 9, 1522&#x2013;1533. 10.1002/cmdc.201300505</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.201300505</ArticleId><ArticleId IdType="pmc">PMC7162318</ArticleId><ArticleId IdType="pubmed">24574246</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zhu C., Bao W., Zhao K., Niu J., Yu X. F., et al. . (2012). Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China. PLoS ONE 7:e32405. 10.1371/journal.pone.0032405</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032405</ArticleId><ArticleId IdType="pmc">PMC3315555</ArticleId><ArticleId IdType="pubmed">22479324</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Regional Office for the Western Pacific  (2018). Hand, Foot and Mouth Disease Situation Update 2018. Available online at: http://iris.wpro.who.int/handle/10665.1/14191</Citation></Reference><Reference><Citation>Xi X., Zhang X. Y., Wang B., Wang T., Wang J., Huang H., et al. . (2013). The interplays between autophagy and apoptosis induced by enterovirus 71. PLoS ONE 8:e56966. 10.1371/journal.pone.0056966</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056966</ArticleId><ArticleId IdType="pmc">PMC3577684</ArticleId><ArticleId IdType="pubmed">23437282</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Cui D. W., Wang L., Cheng J., Sun C. G., Li L. J., et al. . (2018). Genetic characteristics of the P1 coding region of Coxsackievirus A16 associated with hand, foot, and mouth disease in China. Mol. Biol. Rep. 45, 1947&#x2013;1955. 10.1007/s11033-018-4345-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-018-4345-y</ArticleId><ArticleId IdType="pubmed">30182173</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Su W. H., Jin J., Chen J. W., Li X. J., Zhang X. Y., et al. . (2014). Identification of luteolin as enterovirus 71 and Coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening. Viruse 6, 2778&#x2013;2795. 10.3390/v6072778</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6072778</ArticleId><ArticleId IdType="pmc">PMC4113793</ArticleId><ArticleId IdType="pubmed">25036464</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan H., Gao Y. Q., Zhang Y. (2017). Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease. Mol. Med. Rep. 15, 180&#x2013;186. 10.3892/mmr.2016.5966</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2016.5966</ArticleId><ArticleId IdType="pmc">PMC5355648</ArticleId><ArticleId IdType="pubmed">27909723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Xiu J. H., Zhang X., Zhang L. F., Yan K., Qin C., et al. . (2012). Antiviral effect of matrine against human enterovirus 71. Molecule 17, 10370&#x2013;10376. 10.3390/molecules170910370</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules170910370</ArticleId><ArticleId IdType="pmc">PMC6268984</ArticleId><ArticleId IdType="pubmed">22932217</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying X. X., Huang A. L., Xing Y. J., Lan L. P., Yi Z. F., He P. Q. (2017). Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway. Sci. China Life Sci. 60, 417&#x2013;428. 10.1007/s11427-016-0368-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-016-0368-y</ArticleId><ArticleId IdType="pubmed">28251459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Qiao H. S., Lv Y. Z., Wang J. J., Chen X. Q., Hou Y. H., et al. . (2014). Apigenin inhibits enterovirus-71 infection by disrupting viral RNA association with trans-Acting Factors. PLoS ONE 9:e110429. 10.1371/journal.pone.0110429</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0110429</ArticleId><ArticleId IdType="pmc">PMC4199717</ArticleId><ArticleId IdType="pubmed">25330384</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y. Y., Li Y., Jiang W. Q., Zhou L. F. (2015). MAPK/JNK signalling: a potential autophagy regulation pathway. Biosci. Rep. 35:e00199. 10.1042/BSR20140141</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20140141</ArticleId><ArticleId IdType="pmc">PMC4613668</ArticleId><ArticleId IdType="pubmed">26182361</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>